Article
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Journal of clinical microbiology - 1 Jul 1996
Berrouane Y F, Hollis R J, Pfaller M A
Abstract excerpt
Candida krusei is an emerging pathogen that is well known for its propensity to develop resistance to fluconazole and other azoles. Despite the potential clinical significance of C. krusei, little is known of its epidemiology and genetic diversity as defined by the newer DNA-based typing methods....
Topics
- Amphotericin B
- Antifungal Agents
- Candida
- Candidiasis
- DNA, Fungal
- Deoxyribonucleases, Type II Site-Specific
- Drug Resistance, Microbial
- Fluconazole
- Flucytosine
- Genetic Variation
- Humans
- Itraconazole
- Molecular Epidemiology
